Management of Seizures in the Elderly

Current Geriatrics Reports - Tập 3 - Trang 73-82 - 2014
Cynthia M. Correll1, Carl W. Bazil1
1Columbia Comprehensive Epilepsy Center, Columbia University College of Physicians and Surgeons, New York, USA

Tóm tắt

Contrary to what most physicians believe, seizures begin most commonly in the older age group (early childhood is the next most common time). In older patients, detailed history may be even more important to differentiate seizures from other transient neurological complaints often seen at that age. Electroencephalography and magnetic resonance imaging of the brain can also be helpful in the diagnosis. As there are now numerous antiepileptic drugs to choose from, potential adverse effects and drug interactions, as well as efficacy, are particularly important in older patients. This review will outline the diagnosis and causes of seizures in the elderly, as well as the clinical trials and side effect profiles that will help guide management decisions in this age group.

Tài liệu tham khảo

Tallis R, Hall G, Craig I, Dean A. How common are epileptic seizures in old age? Age Ageing. 1991;20:442–8. Hauser WA. Seizure disorders: the changes with age. Epilepsia. 1992;33:S6–S14. Hauser WA, Annegers JF, Kurtland LT. Incident of epilepsy and unprovoked seizures in Rochester, Minnesota. Epilepsia. 1993;34:453–68. Sander JWAS, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatr. 1996;61:433–43. Faught E, Richman J, Martin R, Funkhouser E, Foushee R, Kratt P, et al. Incidence and prevalence of epilepsy among older US Medicare beneficiaries. Neurology. 2012;78:448–53. This study shows the high incidence rate of epilepsy in the elderly population. Leppik IE. Introduction to the International Geriatric Epilepsy Symposium (IGES). Epilepsy Res. 2006;68S:S1–4. Luhdorf K, Jense LK, Plesner AM. Epilepsy in the elderly: life expectancy and causes of death. Acta Neurol Scand. 1987;76:183–90. Ruggles KH, Haessly SM, Berg RL. Prospective study of seizures in the elderly in the Marshfield Epidemiologic Study Area (MESA). Epilepsia. 2001;42:1594–9. Granger N, Convers P, Beauchet O, Imler D, Viallon A, Laurent B, et al. First epileptic seizure in the elderly: electroclinical and etiological data in 341 patients. Rev Neurol. 2002;158:1088–95. Delorenzo RJ, Hauser WA, Towne AR, Boggs JG, Pellock JM, Penberthy L, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996;46:1029–35. Sinha S, Satishchandra S, Kalband BR, Thennarasu K. New-onset status epilepticus and cluster seizures in the elderly. J Clin Neurosci. 2013;20:423–8. This study reveals the high rate of critical presentations of seizures in the elderly requiring ICU management. Conrad J, Pawlowski M, Dogan M, Kovac S, Ritter MA, Evers S. Seizures after cerebrovascular events: risk factors and clinical features. Seizure. 2013;22:275–82. This study highlights the high risk of single seizures and epilepsy following a stroke. Chin RF, Neville BG, Scott RC. A systematic review of the epidemiology of status epilepticus. Eur J Neurol. 2004;11:800–10. Baker GA, Jacoby A, Buck D, Brooks J, Potts P, Chadwick DW. The quality of life of older people with epilepsy: findings from the UK community study. Seizure. 2001;10:92–9. Mclaughlin DP, Pachana MA, McFarland K. Stigma, seizure frequency, and quality of life: the ipact of epilepsy in late adulthood. Seizure. 2008;17:281–7. Haut SR, Katz M, Masur J, Lipton RB. Seizure in the elderly: impact on mental status, mood, and sleep. Epilepsy Behav. 2009;14:540–4. Stefan H. Epilepsy in the elderly: facts and challenges. Acta Neurol Scand. 2011;124:223–37. Sirven JI. Acute and chronic seizures in patients older than 60 years. Mayo Clin Proc. 2001;76:75–83. Bartsch R, Butler C. Transient amnesic syndromes. Nat Rev Neurol. 2013;9:86–97. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology. 2004;62(S2):S24–9. Derry CP, Duncan JS, Berkovic SF. Paroxysmal motor disorders of sleep: the clinical spectrum and differentiation from epilepsy. Epilepsia. 2006;47:1775–91. Olsen EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2002;123:331–9. Kellinghaus C, Loddenkemper T, Dinner DS, Lachhwani D, Luders HO. Non-epileptic seizures of the elderly. J Neurol. 2004;251:704–9. Duncan R, Oto M, Martin E, Pelosi A. Late onset psychogenic nonepileptic attacks. Neurology. 2006;66:1644–7. Behrouz R, Heriaud L, Benbadis SR. Late-onset psychogenic nonepileptic seizures. Epilepsy Behav. 2006;8:649–50. Luhdorf K, Hensen LK, Plesner AM. Epilepsy in the elderly: incidence, social function, and disability. Epilepsia. 1986;27:135–71. Sander JWAS, Hart YM, Johnson AJ, Shorvon SD. The National General Practice study of epilepsy: newly diagnosed seizures in a general population. Lancet. 1990;336:1267–71. Forgren L, Bucht G, Eriksson S, Bergmark L. Incidence and clinical characterization of unprovoked seizures in adults - a prospective population-based study. Epilepsia. 1996;37:224–9. Rossi C, De Herdt V, Dequatre-Ponchelle N, Henon H, Leys D, Cordonnier C. Incidence and predictors of late seizures in intracerebral hemorrhages. Stroke. 2013;44:1723–5. This study reports an increased risk of late seizures with intracerebral bleeds, particularly if the bleed has cortical involvement. Jungehulsing GJ, Heuschmann PU, Holtkamp M, Schwab S, Kolominsky-Rabas PL. Incidence and predictors of post-stroke epilepsy. Acta Neurol Scand. 2013;127:427–30. This study reports an increased risk of late seizures after a stroke, with increased risk associated with severity of the stroke. Li X, Breteler MMB, de Bruyne MC, Meinardi H, Hauser WA, Hofman A. Vascular determinant of epilepsy: the Rotterdam study. Epilepsia. 1997;38:1216–20. Leone MA, Tonini MC, Bogliun G, Gionco M, Tassinari T, Bottacchi E, et al. Risk factors for a first epileptic seizure after stroke: a case control study. J Neurol Sci. 2009;277:138–42. Pohlmann-Eden B, Fatar M, Hennerici M. The preserved cortical island sign is highly predictive of postischemic seizures. Cerebrovasc Dis. 2001;12:282. So EL, Annegers JF, Hauser WA, O’Brien PC, Whisnant JP. Population-based study of seizure disorders after cerebral infarction. Neurology. 1996;46:350–5. Kwan J, Guenther A. Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis. Cochrane Database Syst Rev. 2006;3, CD005501. Gilad R. Management of seizures following a stroke: what are the options? Drugs Aging. 2012;29:533–8. Scarmeas N, Honig LS, Choi H, Cantero J, Brandt J, Blacker D, et al. Seizures in Alzheimer disease - who, when and how common? Arch Neurol. 2009;66:992–7. Amatniek JC, Hauser WA, Delcastillo-Castaneda C, Jacobs DM, Marder K, Bell K, et al. Incident and predictors of seizures in patients with Alzheimer’s disease. Epilepsia. 2006;47:867–72. McAreavey MJ, Ballinger BR, Fenton GW. Epileptic seizures in elderly patients with dementia. Epilepsia. 1992;33:657–60. Rao SC, Dove G, Cascino GD, Petersen RC. Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcomes. Epilepsy Behav. 2009;14:118–20. Imfeld P, Bodmer M, Schuerch M, Jick SS, Meier CR. Seizures in patients with Alzheimer’s disease or vascular dementia: a population based nested case-control analysis. Epilepsia. 2013;54:700–7. This large case-control study highlights the increased risk of seizures in patients with Alzheimer’s disease or vascular dementia. Hesdorffer DC, Hauser WA, Anneger JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology. 1996;46:727–30. Glantz MJ, Cole BF, Forsyth PA, et al. Practive parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;54:1886–93. Berg AT, Shinnar S. The risk for seizure recurrence following a first unprovoked seizure: a quantitative review. Neurology. 1991;41:965–72. Hauser WA, Stephen SR, Annegers JF, Anderson VE. Seizure recurrence after a first unprovoked seizure: an extended follow-up. Neurology. 1990;40:1163–70. Salinsky M, Kanter R, Dasheiff RM. Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curse. Epilepsia. 1987;28:331–4. Widdess-Walsh P, Sweeney BJ, Galvin R, McNamara B. Utilization and yield of EEG in the elderly population. J Clin Neurophysiol. 2005;22:253–5. Davidson PN, Davidson KA. Electroencephalography in the elderly. Neurodiagn J. 2012;52:3–19. Nguyen MV, Ourabah Z, Bourdali Y, Gouronnec A, Motamed G, Al-Rifal S, et al. The yield of routine EEG in geriatric patients: a prospective hospital based study. Neurophysiol Clin. 2010;40:249–54. Waton P, Conroy A, Moran G, Duncan S. Retrospective study of sensitivity and specificity of EEG in the elderly compared with younger age group. Epilepsy Behav. 2012;25:408–11. Drury I, Beydoun A. Interictal epileptiform activity in the elderly patients with epilepsy. Electroencephalogr Clin Neurophysiol. 1998;106:369–73. Lancman ME, O’Donovan C, Dinner D, Coelho M, Luders HO. Usefulness of prolonged video-EEG monitoring in the elderly. J Neurol Sci. 1996;142:54–8. Drury I, Selwa LM, Schuh LA, Kapur J, Varma N, Beydoun A, et al. Value of inpatient diagnostic CCTV-EEG monitoring in the elderly. Epilepsia. 1999;40:1100–2. McBride AE, Shih TT, Hirsch LJ. Video-EEG monitoring in the elderly: a review of 94 patients. Epilepsia. 2002;43:165–9. Baheti NN, Radhakrishnan A, Radhakrishnan K. A critical appraisal on the utility of long-term video-EEG monitiring in older adults. Epilepsy Res. 2011;97:12–9. Mattson R, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985;313:145–51. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Eng J Med. 1992;327:765–71. Ramsay RE, Rowan AJ, Slater JD, Collins J, Nemire R, Ortiz WR, et al. Effect of age on epilepsy and its treatment: results from the VA Co-operative study. Epilepsia. 1994;35(S8):91. Karceski S, Morrell MJ, Carpenter D. Treatment of epilepsy in adults: expert opinion. Epilepsy Behav. 2005;7:S1–S64. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for the treatment of partial epilepsy: an unblinded randomized controlled trial. Lancet. 2007;369:1000–15. Brodie MJ, Richens A, Yuen AW. Double-blind comparisons of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet. 1995;345:476–9. Steiner TJ, Dellaportas CI, Findley LF, Gross M, Gibberd FB, Perkin GD, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia. 1999;40:601–7. Rowan AJ, Ramsay RE, Collins JF. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. 2005;64:1868–73. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res. 1999;37:81–7. Saetre E, Perucca E, Isojarvi J, Gjerstad L. An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia. 2007;48:1292–302. Dogan EG, Usta BE, Bilgen R, Senol Y, Aktekin B. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy. Epilepsy Behav. 2008;13:156–61. Kutluay E, McCague K, D’Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav. 2003;4:175–80. Ramsay RE, Uthman B, Pryor FM, Rowan AJ, Bainbridge J, Spitz M, et al. Topiramate in older patients with partial onset seizures: a pilot double-blind, dose-comparison study. Epilepsia. 2008;49:1180–5. Groselj J, Guerrini R, Van Oene J, Lahaye M, Schreiner A, Schwalen S. Experience with topiramate monotherapy in elderly patient with recent onset epilepsy. Acta Neurol Scan. 2005;112:1440–50. Alsaadi RM, Keopmans S, Aperson M, Farias S. Levetiracetam monotherapy for elderly patients with epilepsy. Seizures. 2004;13:58–60. Ferrendellli JA, French J, Leppik I, Morrell MJ, Herbeuval A, Han J, et al. Use of levetiracetam in a population of patients aged 65 years and older: a subset analysis of the KEEPER trial. Epilepsy Behav. 2004;4:702–9. Kutlu G, Gomceli YB, Unal Y, Inan LE. Levetiracetam monotherapy for late poststroke seizures in the elderly. Epilepsy Behav. 2008;13:542–4. Consoli D, Bosco D, Postorino P, Galati F, Plastino M, Perticoni GF. Levetiracetam versus carbamazepine in patients with late poststroke seizures: a multicenter prospective randomized open-label study (EpIC Project). Cerebrovasc Dis. 2012;34:282–9. This randomized multicenter trial of LEV versus CBZ to treat late post-stroke epilepsy showed no difference in seizure freedom rates, but increased adverse events and cognitive testing in subjects treated with CBZ. DeToledo JC. Changing presentation of seizures with aging: clinical and etiological factors. Gerontology. 1999;45:329–35. Sommer BR, Fenn HH. Review of topiramate for the treatment of epilepsy in elderly patients. Clin Interv Aging. 2010;5:89–99. Tombini M, Pellegrino G, Di Pino G, Assenza G. Zonisamide for seizures in Parkinson’s disease with dementia. Seizure. 2013;22:324–5. This case report suggests zonisamide may be the treatment of choice in patients with seizures and comorbid Parkinson’s Disease. Verrotti A, Coppola G, Parisi P, Mohn A, Chiarelli F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112:1–10. Ensrud KE, Walczak RS, Blackwell TI, Ensrud ER, Barrett-Connor E, Orwoll ES. Antiepileptic drug use and rates of hip bone loss in older men: a prospective study. Neurology. 2008;71:723–30. Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand. 1999;99:269–75. Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts ACG. Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy. Neurology. 2006;66:1318–24. Ahmad BS, Hill KD, O’Brien TJ, Gorelik A, Habib N, Wark JD. Falls and fractures in patients chronically treated with antiepileptic drugs. Neurology. 2012;79:145–51. This large cross-sectional study showed increased rates of osteoporosis and fractures in the elderly on AEDs, which could not be accounted for solely by fractures due to seizures. Lazzari AA, Dussault PM, Thakore-James M, Gagnon D, Baker E, Davis SA, et al. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy–Antiepileptic drug and osteoporosis prevention trial. Epilepsia. 2013;54:1997–2004. This double blind randomized control trial of preventative bisphosphonate use in patients on chronic AEDs showed improved BMD and decreased fractures in the patient group treated with a bisphosphonate. Faught E, Duh MS, Weiner JR, Geurin A, Cunnington MC. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM study. Neurology. 2008;71:1572–8. Ettinger AB, Baker GA. Best clinical and research practice in epilepsy of older people: focus on antiepileptic drug adherence. Epilepsy Behav. 2009;15:S60–3. Zeber JE, Copeland LA, Pugh MJV. Variation in antiepileptic drug adherence among older patients with new onset epilepsy. Ann Pharmacol. 2010;44:1896–904. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–7. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003;38:843–53. Leppik IE. Metabolism of antiepileptic medication: newborn to elderly. Epilepsia. 1992;33(S4):S32–40. Landmark CJ, Baftiu A, Tysse I, Valso B, Larsson PG, Rytter E, et al. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Ther Drug Monit. 2012;34:440–5. Liow K, Barkley GL, Pollard JR, Harden CL, Bazil CW. Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy. Neurology. 2007;68:1249–50. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Eng J Med. 2000;342:314–9. Stephen LJ, Kelly K, Mohanraj R, Brodie MJ. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav. 2006;8:434–7. Besocke AG, Rosso B, Cristiano E, Valiensi SM, Garcia Mdel C, Gonorazky SE, et al. Outcomes of newly-diagnosed epilepsy in older patients. Epilepsy Behav. 2013;27:29–35. This study highlights the fact that elderly with newly diagnosed epilepsy have good response rates to medications. Sirven JI, Malamut BL, O’Connor MJ, Sperly MR. Temporal lobectomy outcome in older versus younger adults. Neurology. 2000;54:2166–70. Acosta I, Vale F, Atum WO, Benbadis SR. Epilepsy surgery after age 60. Epilepsy Behav. 2008;12:324. Grivas A, Schramm J, Kral T, von Lehe M, Helmstaedter C, Elger CE, et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia. 2006;47:1364–72.